Report an announcement or request its removal

An error, information concerning you or content that has no place on Clarsource: let the newsroom know. No account required.

  • ImmediateAcknowledgement and tracking number
  • 72 business hours*Reasoned response to your request
  • 24 business hours*Concealment of manifestly unlawful content

Already submitted a request? Track your request using its tracking number.

01

Which announcement?

Copy the page URL or the nw_… ID at the bottom of the structured listing.
UnclaimedOSE IMMUNOTHERAPEUTICS · 29 October 2026

OSE Immunotherapeutics Reports Additional Positive Results of Combi-TED Phase 2 Randomized Trial with Tedopi® (OSE2101) in metastatic Non-Small Cell Lung Cancer

View announcement
02

What is the issue?

What you are requesting
03

You are

To reach you if needed. Never published or shared with the issuer.
So we can reply to you. Never published or shared with the issuer.
04

The details

Supporting document optional

Anti-bot check in progress, please wait a moment and try again.

Your name and email are never shared with the issuer.

* Times are calculated from receipt of a complete request, subject to its validity under our editorial policy.